Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Posts Tagged ‘Jeremy Green’

stock, market, tablet, screen, trade, forex, graph, chart, touch, rate, business, global, data, interest, information, hand, index, visual, growth, finger, internet, nyse, pc, retail,

Is Redmile Group Right to Bet on Array Biopharma Inc (ARRY), Amicus Therapeutics, Inc. (FOLD) & Two Other Stocks?

Despite of all the negative sentiment looming around them, hedge funds had a pretty solid run for much of this year, generating positive returns for seven......(read more)
dna, bio, clone, helix, medical, health, research, cell, gene, microscopic, render, tech, chemistry, molecular, liquid, life, biotechnology, technology, medicine, molecule,

Redmile Group Sticking With Healthcare Picks After Rough Q1

Redmile Group is a San Francisco-based, healthcare-focused hedge fund founded and managed by Jeremy Green, an Oxford alum with more than 20 years of experience......(read more)
money, expensive, medical, examination, patient, business, concept, clinic, stethoscope, wealth, insurance, finance, dollar, disease, bank, treatment, sick, medicine,

Redmile Group’s Top Q4 Moves as Its Long Positions Show Gains of 20% in 2015

Redmile Group is a San Francisco-based investment firm managed by Jeremy Green, which primarily focuses on the healthcare sector. Redmile has an equity......(read more)
James Flynn Deerfield Management

Billionaires James Flynn, David Abrams, Among the Elite Investors Buying These 4 Stocks Last Week

Individual investors might find hedge fund investing quite expensive, considering the 2-and-2o fee structure most hedge funds employ. However, mimicking......(read more)
Warren Buffet, is Warren Buffet success personified, Suzanne Woolley

Buffett, Starboard Among the Elite Investors to Disclose New Moves

The deadline for the current round of 13F filings, for the quarterly period that ended December 31, is February 15. Most market participants find these......(read more)
Abbvie ABBV biopharmaceuticals cell blood dna gene stem test biotech research

Redmile Group Continues To Agressively Buy Shares Of This Biotech

Correction: This article has previously mistakenly stated that the Redmile Group had sold shares of Array Biopharma. Therefore, the title and the first......(read more)
Most Affordable Medical Schools in Europe

Redmile Group Fortifies Position In Array Biopharma Inc (ARRY); Broadwood Capital Boosts Stake In STAAR Surgical Company (STAA)

Jeremy Green, the manager of Redmile Group, is still bullish on Array Biopharma Inc (NASDAQ:ARRY) having further increased his holding of the stock......(read more)
cheerful pharmacist chemist woman standing in pharmacy drugstore

Redmile Group Is Putting More Money Into Array BioPharma Inc. (ARRY)

Jeremy Green’s Redmile Group has just acquired more shares of Array BioPharma Inc. (NASDAQ:ARRY). In a Form 4 filed with the U.S. Securities and Exchange......(read more)
Gilead Sciences, Inc. (NASDAQ:GILD)

Gilead Sciences (GILD), AstraZeneca (AZN), Bellicum Pharmaceuticals (BLCM): Redmile Group’s Top New Picks

Jeremy Green’s Redmile Group entered several new positions last quarter, as revealed by the 13F Form it filed with the U.S. Securities and Exchange......(read more)
EHTH EHealth Inc logo

eHealth, Inc. (EHTH): Deerfield Management Picked a Bad Time to Buy 1 Million Shares of This Company

eHealth, Inc. (NASDAQ:EHTH) appears to have a major proponent in James E Flynn’s Deerfield Management, as the health-focused hedge fund continues......(read more)
Amicus Therapeutics

Amicus Therapeutics, Inc. (FOLD): Redmile Group Trims Position and Books Some Profits from Long-Term Investment

Jeremy Green‘s Redmile Group has also reduced its stake in Amicus Therapeutics, Inc. (NASDAQ:FOLD), after yesterday, William Leland Edwards’......(read more)
Amicus Therapeutics

Amicus Therapeutics Inc. (FOLD): Palo Alto Investors Sells Half of its Stake At Sky-High Valuation

William Leland Edwards’ Palo Alto Investors disclosed today a 50% decrease in its exposure to Amicus Therapeutics, Inc. (NASDAQ:FOLD). According to......(read more)

HeartWare International Inc (HTWR), Republic Services Inc. (RSG): Adage Capital Partners and Cascade Investment Boost Exposure

Not only company officers qualify as insiders. Shareholders that own more than 10% of a company’s outstanding stock are also considered to be insiders......(read more)

HeartWare International Inc (HTWR): Adage Capital Ups Stake to 11.2%

Adage Capital Partners, a hedge fund led by Phill Gross and Robert Atchinson, has recently disclosed upping its stake in HeartWare International Inc......(read more)
Amicus Therapeutics

Perceptive Advisors Buys 4.0 Million Shares Of Amicus Therapeutics Inc. (FOLD)

Perceptive Advisors, managed by Joseph Edelman, is bullish on Amicus Therapeutics Inc. (NASDAQ:FOLD). In a new filing with the U.S. Securities and Exchange......(read more)
Ophthotech

James Litinsky is Bullish on Ophthotech Corp (OPHT); JHL Capital Boosts Stake in the Company

James H. Litinsky‘s JHL Capital Group has boosted its stake in Ophthotech Corp (NASDAQ:OPHT) to 1.78 million shares, a new filing with the SEC......(read more)

Heartware International, Inc. (HTWR) Now Has More Adage Capital Management Interest

Phill Gross And Robert Atchinson‘s Adage Capital Management has raised its exposure to Heartware International, Inc. (NASDAQ:HTWR) to 836,190 shares......(read more)

Jeremy Green, Redmile Group Boost Position in Amicus Therapeutics, Inc. (FOLD)

Jeremy Green‘s Redmile Group has significantly surged its position in Amicus Therapeutics, Inc. (NASDAQ:FOLD), a new filing with the SEC revealed......(read more)
Jim Chanos puppeteer

Jeremy Green, Redmile Group Drop Cyclacel Pharmaceuticals Like It’s Hot

Jeremy Green, Redmile Group: In a passive 13G filing with the SEC just now, the San Francisco-based Redmile Group, managed by Jeremy Green, has closed......(read more)
Vanguard Health Systems, Inc. (NYSE:VHS)

Vanguard Health Systems, Inc. (VHS): Insiders Aren’t Crazy About It But Hedge Funds Love It

Should Vanguard Health Systems, Inc. (NYSE:VHS) investors track the following data? To the average investor, there are a multitude of gauges shareholders......(read more)

This Metric Says You Are Smart to Buy Amicus Therapeutics, Inc. (FOLD)

Is Amicus Therapeutics, Inc. (NASDAQ:FOLD) a good investment? Now, according to many investors, hedge funds are assumed to be overrated, outdated investment......(read more)
Pacific Biosciences of California (NASDAQ:PACB)

Should You Buy Pacific Biosciences of California (PACB)?

To the average investor, there are tons of metrics shareholders can use to analyze Mr. Market. A duo of the best are hedge fund and insider trading interest......(read more)
Kythera Biopharmaceuticals Inc (NASDAQ:KYTH)

What Hedge Funds Think About Kythera Biopharmaceuticals Inc (KYTH)

To the average investor, there are tons of methods market participants can use to track publicly traded companies. Two of the most useful are hedge fund......(read more)
Insulet Corporation (NASDAQ:PODD)

Should You Avoid Insulet Corporation (PODD)?

To many of your peers, hedge funds are assumed to be delayed, outdated financial tools of a period lost to current times. Although there are more than......(read more)
AstraZeneca plc (ADR) (NYSE:AZN)

Do Hedge Funds and Insiders Love AstraZeneca plc (ADR) (AZN)?

What’s a smart AstraZeneca plc (ADR) (NYSE:AZN) investor to do? At the moment, there are dozens of gauges investors can use to track Mr. Market......(read more)
ABIOMED, Inc. (NASDAQ:ABMD)

ABIOMED, Inc. (ABMD): Hedge Funds Are Bullish and Insiders Are Undecided, What Should You Do?

Is ABIOMED, Inc. (NASDAQ:ABMD) a good investment? In the 21st century investor’s toolkit, there are tons of gauges investors can use to track the equity......(read more)
Capital Senior Living Corporation

This Metric Says You Are Smart to Sell Capital Senior Living Corporation (CSU)

To the average investor, there are dozens of methods investors can use to track publicly traded companies. Two of the best are hedge fund and insider......(read more)
Cepheid (NASDAQ:CPHD)

This Metric Says You Are Smart to Sell Cepheid (CPHD)

Is Cepheid (NASDAQ:CPHD) a good investment? To many of your peers, hedge funds are viewed as delayed, old investment tools of an era lost to time. Although......(read more)
Puma Biotechnology Inc (NYSE:PBYI)

Here is What Hedge Funds and Insiders Think About Puma Biotechnology Inc (PBYI)

What’s a smart Puma Biotechnology Inc (NYSE:PBYI) investor to do? In today’s marketplace, there are dozens of methods market participants can......(read more)
Align Technology, Inc. (NASDAQ:ALGN)

Is Align Technology, Inc. (ALGN) Going to Burn These Hedge Funds?

To the average investor, there are many gauges shareholders can use to analyze the equity markets. Some of the most innovative are hedge fund and insider......(read more)
Orexigen Therapeutics, Inc. (NASDAQ:OREX)

Should You Avoid Orexigen Therapeutics, Inc. (OREX)?

Should smart Orexigen Therapeutics, Inc. (NASDAQ:OREX) keep in mind the following data? In the financial world, there are a multitude of metrics shareholders......(read more)
Array Biopharma Inc (NASDAQ:ARRY)

Array Biopharma Inc (ARRY): Hedge Funds Are Bearish and Insiders Are Undecided, What Should You Do?

Is Array Biopharma Inc (NASDAQ:ARRY) a good investment? At the moment, there are many methods investors can use to analyze Mr. Market. Some of the most......(read more)
NuVasive, Inc. (NASDAQ:NUVA)

Here is What Hedge Funds Think About NuVasive, Inc. (NUVA)

Is NuVasive, Inc. (NASDAQ:NUVA) a good investment? To many of your fellow readers, hedge funds are viewed as delayed, outdated investment tools of a......(read more)
Universal Health Services, Inc. (NYSE:UHS)

Hedge Funds Aren’t Crazy About Universal Health Services, Inc. (UHS) Anymore

Universal Health Services, Inc. (NYSE:UHS) investors: pay attention. If you were to ask many of your peers, hedge funds are viewed as overrated, outdated......(read more)
Cerus Corporation

Do Hedge Funds and Insiders Love Cerus Corporation (CERS)?

Cerus Corporation (NASDAQ:CERS) has experienced an increase in hedge fund sentiment in recent months. In today’s marketplace, there are a multitude......(read more)
Chuck Royce

Hedge Funds Are Betting On Globus Medical Inc (GMED)

Globus Medical Inc (NYSE:GMED) has experienced an increase in hedge fund interest of late. In the eyes of most traders, hedge funds are seen as slow,......(read more)
Insulet Corporation (NASDAQ:PODD)

Should You Buy Insulet Corporation (PODD)?

Insulet Corporation (NASDAQ:PODD) was in 14 hedge funds’ portfolio at the end of the first quarter of 2013. PODD has experienced an increase in......(read more)

Hedge Funds Are Buying Amicus Therapeutics, Inc. (FOLD)

Amicus Therapeutics, Inc. (NASDAQ:FOLD) was in 12 hedge funds’ portfolio at the end of March. FOLD shareholders have witnessed an increase in enthusiasm......(read more)